Vivimed Labs gets CCI nod to products sale deal with Clariant
Advertisement
New Delhi: Drug firm Vivimed Labs said the Competition Commission has given its approval to a deal with Clariant Chemicals India to sell some products in its speciality chemicals division.
"The Competition Commission of India vide its letter dated December 21, 2015, has granted its approval, under Section 31(1) of the Competition Act, 2002, with respect to the proposed acquisition of certain products in Speciality Chemicals division of the company by Clariant India Ltd," Vivimed Labs said in a BSE filing.
The order of the CCI will be received in due course of time, the company said, adding that other permits and approvals required for the deal are awaited and expected shortly.
In September, Vivimed had signed a pact for sale of some of products in its speciality chemicals division to Clariant Chemicals India at an enterprise value of Rs 380 crore.
The company has signed a definitive agreement for the transfer and sale of identified products within speciality division to company Clariant AGs subsidiary Clariant Chemicals India Ltd.
"The Competition Commission of India vide its letter dated December 21, 2015, has granted its approval, under Section 31(1) of the Competition Act, 2002, with respect to the proposed acquisition of certain products in Speciality Chemicals division of the company by Clariant India Ltd," Vivimed Labs said in a BSE filing.
The order of the CCI will be received in due course of time, the company said, adding that other permits and approvals required for the deal are awaited and expected shortly.
In September, Vivimed had signed a pact for sale of some of products in its speciality chemicals division to Clariant Chemicals India at an enterprise value of Rs 380 crore.
The company has signed a definitive agreement for the transfer and sale of identified products within speciality division to company Clariant AGs subsidiary Clariant Chemicals India Ltd.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.